fig1
Figure 1. Nomogram for predicting severe immune-related adverse events following TACE plus immunotherapy in HCC patients. TACE: Transcatheter arterial chemoembolization; HCC: hepatocellular carcinoma; NLR: neutrophil-to-lymphocyte ratio; Treg: regulatory T cell.
